Such-Lupe

FAQs

How are the earnings per share and the diluted earnings per share calculated?

Earnings per share

Earnings per share (EPS) is a frequently used financial tool.

In accordance with the International Financial Reporting Standards (IFRS) used by STADA, we calculate our earnings per share by dividing our consolidated net income by the number of our shares.

If the number of shares changes during the reporting period, for example as a result of a capital increase, IFRS stipulates that earnings per share should be calculated by dividing consolidated net income by the average number of shares during the reporting period.

Pursuant to IAS 33 § 20 in conjunction with IAS 33 § 22, a capital increase from existing funds changes the average number of shares without any concomitant change in the level of resources. The number of common shares in issue prior to the capital increase is adjusted in accordance with the proportional change in the number of common shares in issue after the share issue as if the event (the de-facto 1:1 stock split) had occurred at the beginning of the period under review. For the purposes of historical comparison, the historical figure for the average number of shares in each financial year ending prior to the conversion date will be doubled to adjust for the 1:1 stock split when calculating the earnings per share.

In the first half of 2010 the average number of shares (after deducting STADA's own shares) was 58,752,205, second quarter: 58,757,116 (2010: first quarter: 58,747,293; 2009: fiscal year in total 58,662,392, fourth quarter: 58,685,910, first nine months accumulated 58,654,553, third quarter: 58,655,522, first half: 58,654,069, second quarter: 58,655,352 (2009: first quarter: 58,652,785; 2008: fiscal year in total: 58,632,021, fourth quarter: 58,649,700, first nine months accumulated: 58,626,128, third quarter: 58,647,693, first half accumulated: 58,615,346, second quarter: 58,622,791, first quarter: 58,607,901; 2007: fiscal year in total:58,315,643, fourth quarter: 58,498,927, first nine months accumulated: 58,254,549, third quarter: 58,317,603, first half accumulated: 58,223,021, second quarter: 58,224,157, first quarter: 58,221,886).

The exact rules for calculating earnings per share (EPS) according to IAS 33.10 can be found here

Diluted earnings per share

Diluted earnings per share (EPS diluted) is another frequently used financial tool, which takes account of the outstanding options.

The exact rules for calculating diluted earnings per share (EPS diluted) according to IAS 33.31 can be found here

As the calculation indicates, the diluted number of shares used in the computation is also dependent on the respective stock price on the qualifying date. In the first half of 2010 the average number of shares (including potentially diluted shares and after deducting STADA's own shares) was 60,212,673, second quarter: 60,326,057 (2010: first quarter:60,096,130; 2009: fiscal year in total 58,921,689, fouth quarter: 59,555,995, first nine months accumulated 58,654,553, third quarter: 58,764,691, first half: 58,654,069, second quarter: 58,655,352, first quarter: 58,652,785; 2008: fiscal year in total: 59,349,246, fourth quarter: 59,366,925, first nine months accumulated: 60,144,786, third quarter: 60,166,351, first half accumulated: 60,949,458, second quarter: 60,956,903, first quarter: 60,964,889; 2007: fiscal year in total: 60,549,400, fourth quarter: 60,732,684, first nine months accumulated: 60,708,038, third quarter: 60,771,092, first half accumulated: 60,862,423: second quarter: 60,863,558, first quarter: 60,807,129).

Back Forward
Here we have provided you with an overview of important facts and information from strategy through business segments, sales networks and the history of STADA Arzneimittel AG. More
Here you can read an online version of the last 4 financial reports on your screen, download the PDF or order a hard copy. Older financial reports are available in PDF format from our archive. More
The management of STADA Arzneimittel AG introduce themselves! Here you will find the members of the Executive Board, the Supervisory Board and the Advisory Board. More
Here you will find corporate news and ad-hoc releases that you can read directly on your screen or download as a PDF file. Older releases are available for you in our archive. More
Notices in accordance with the German Securities Trading Act (WpHG) as well as the annual document and the annual financial statements of STADA Arzneimittel AG can be viewed here. More

 

(c) 2010 STADA Arzneimittel AG, Stadastraße 2-18, 61118 Bad Vilbel, Telefon 06101 603-0, Fax 06101 603-259, e-Mail: info@stada.de